Corrigendum to “Oral minocycline therapy as first-line treatment in patients with Myalgic encephalomyelitis and long COVID: A pilot study” [eNeurologicalSci 38 (2025) 100537].
Saved in:
| Main Author: | Kunihisa Miwa |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-03-01
|
| Series: | eNeurologicalSci |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2405650225000115 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Oral minocycline therapy as first-line treatment in patients with Myalgic encephalomyelitis and long COVID: A pilot study
by: Kunihisa Miwa
Published: (2025-03-01) -
Plasma cell targeting with the anti-CD38 antibody daratumumab in myalgic encephalomyelitis/chronic fatigue syndrome—a clinical pilot study
by: Øystein Fluge, et al.
Published: (2025-07-01) -
Myalgic Encephalomyelitis: A legal guide to the perplexed
by: W.P. de Villiers
Published: (2005-08-01) -
Correction: Plasma cell targeting with the anti-CD38 antibody daratumumab in myalgic encephalomyelitis/chronic fatigue syndrome—A clinical pilot study
by: Frontiers Production Office
Published: (2025-08-01) -
Erratum to “Cerebral syphilitic gumma mimicking a brain tumor that enlarged temporarily after commencing antibiotic treatment” [eNeurologicalSci 29 (2022) 100436]
by: Yoshiaki Takahashi, et al.
Published: (2025-06-01)